Truqap Unpacked: How Capivasertib Stops Cancer Cells in Their Tracks

Truqap (Capivasertib) is one of the precision-based treatments for breast cancer developed using advanced molecular and pharmacological research. The article mainly focuses on the clear conceptual review of Truqap.Patients researching targeted therapies often compare treatment options along with the capivasertib price in India to understand long-term affordability before starting therapy.

Treatment Indications of Truqap

Truqap is indicated in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced (spread neighbouring places) or metastatic (spread to other parts of the body) breast cancer with one or more PIK3CA/AKT1/PTEN-alterations as detected by an FDA-approved test following progression on at least one endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing adjuvant therapy. Due to limited availability, many patients seek guidance on how to buy capivasertib in India through authorized medical access channels.

Contraindications of Truqap

Capivasertib is not indicated in patients who are hypersensitive to Truqap or any of its components. Before starting treatment, physicians also discuss sourcing options for patients who prefer to buy capivasertib online in India under prescription compliance.

How does Truqap act in your body?

Capivasertib is the key component present in the Truqap. It obstructs the activity of serine/threonine kinase (AKT) 1, 2 and 3 (enzymes) which play a crucial role in growth of cancer cells mutations in the PIK3CA, AKT1 or PTEN genes. Capivasertib works by preventing the growth of all the three enzymes (AKT1, AKT2, AKT3).

Based on treatment protocols, oncologists may recommend patients to buy capivasertib tablet in India in specific strengths aligned with therapy goals.

Dosage recommendations

The recommended dose of Truqap is 400mg twice daily taken orally, with or without food for 4 days followed by 3 days off.
Swallow the tablet. Never chew, crush or split it.
Instruct patients that if the dose is missed, it can be taken within 4 hours after the time it is usually taken.
If more than 4 hours has passed, skip the dose. Take the next dose at the usual time.
If the patient vomits soon after taking the dose, an additional dose should not be taken. The next dose should be taken at the usual time.

Depending on the prescription, patients may be advised to buy capivasertib 160 mg tablet in India or buy capivasertib 200mg tablet in India to maintain dosing accuracy.

Side-effects

The most common side-effects of Truqap are
Hyperglycemia (high blood sugar levels)
Stomatitis
Diarrhoea, nausea and vomitings
Cutaneous adverse reactions (skin problems) such as erythema multiforme (EM), palmar-plantar erythrodysesthesia, and drug reaction with eosinophilia and systemic symptoms (DRESS).
Decreased lymphocytes
Decreased hemoglobin
Decreased leukocytes
Increased triglycerides
Decreased neutrophils
Increased creatinine (kidney functioning)

Patients prescribed the branded formulation may choose to buy capivasertib (truqap) tablet in India based on medical advice.

Precautions before the start of the treatment

Patients who are pregnant have a risk of fetal-risk, hence they are not advised to take the treatment.
Lactating mothers are advised not to breastfeed their babies during the treatment.

During treatment planning, healthcare providers also explain the capivasertib tablet price in India to ensure transparency and continuity of care.

For inquiries related to the availability and import of Truqap through the Named Patient Program, please connect with us via 24/7QualityMeds.